These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18855105)

  • 1. Cardiovascular risk factors and mortality in patients with coronary heart disease.
    Prugger C; Wellmann J; Heidrich J; Brand-Herrmann SM; Keil U
    Eur J Epidemiol; 2008; 23(11):731-7. PubMed ID: 18855105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Secondary prevention of coronary heart disease. Results from EuroASPIRE I and II in the region of Münster, Germany].
    Heidrich J; Liese AD; Kalic M; Winter-Enbergs A; Wellmann J; Roeder N; Kerber S; Breithardt G; Scheld HH; Kleine-Katthöfer P; Keil U
    Dtsch Med Wochenschr; 2002 Mar; 127(13):667-72. PubMed ID: 11928058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of secondary prevention practice in poststroke and coronary heart disease patients.
    Vaněk J; Mayer O; Seidlerová J; Bruthans J; Kielbergerová L; Wohlfahrt P; Krajčoviechová A; Filipovský J; Cífková R
    Public Health; 2016 Aug; 137():64-72. PubMed ID: 26996311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of classical risk factors and their control in coronary patients: a follow-up of the EUROASPIRE I cohort.
    De Bacquer D; De Backer G; Ostör E; Simon J; Pyörälä K;
    Eur J Cardiovasc Prev Rehabil; 2003 Aug; 10(4):289-95. PubMed ID: 14555885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual risk of cardiovascular mortality in patients with coronary heart disease: the EUROASPIRE risk categories.
    De Bacquer D; Dallongeville J; Kotseva K; Cooney MT; Pajak A; Deckers JW; Mayer O; Vanuzzo D; Lehto S; Fras Z; Östor E; Ambrosio GB; De Backer G; Wood D; Keil U; Sans S; Graham I; Pyörälä K
    Int J Cardiol; 2013 Sep; 168(2):910-4. PubMed ID: 23157810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of secondary prevention of coronary heart disease. Results of the EUROSPIRE study in the Munster region].
    Enbergs A; Liese A; Heimbach M; Kerber S; Scheld HH; Breithardt G; Kleine-Katthöfer P; Keil U
    Z Kardiol; 1997 Apr; 86(4):284-91. PubMed ID: 9235800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality and morbidity from coronary heart disease attributable to passive smoking.
    Heidrich J; Wellmann J; Heuschmann PU; Kraywinkel K; Keil U
    Eur Heart J; 2007 Oct; 28(20):2498-502. PubMed ID: 17507368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease.
    Natarajan S; Liao Y; Cao G; Lipsitz SR; McGee DL
    Arch Intern Med; 2003 Jul; 163(14):1735-40. PubMed ID: 12885690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.
    Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
    Eur J Prev Cardiol; 2016 Apr; 23(6):636-48. PubMed ID: 25687109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of smoking combined with another risk factor on the risk of mortality from coronary heart disease and stroke: pooled analysis of 10 Japanese cohort studies.
    Nakamura K; Nakagawa H; Sakurai M; Murakami Y; Irie F; Fujiyoshi A; Okamura T; Miura K; Ueshima H;
    Cerebrovasc Dis; 2012; 33(5):480-91. PubMed ID: 22517421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for coronary heart disease and survival after myocardial infarction.
    Nauta ST; Deckers JW; van der Boon RM; Akkerhuis KM; van Domburg RT
    Eur J Prev Cardiol; 2014 May; 21(5):576-83. PubMed ID: 22977276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration and effects of secondary prevention measures in coronary heart disease patients from Serbia according to gender and cardiometabolic risk.
    Tasic I; Lazarevic G; Kostic S; Djordjevic D; Simonovic D; Rihter M; Vulic D; Stefanovic V
    Acta Cardiol; 2010 Aug; 65(4):407-14. PubMed ID: 20821933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study.
    De Bacquer D; De Smedt D; Kotseva K; Jennings C; Wood D; Rydén L; Gyberg V; Shahim B; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D; Wagner M; De Backer G;
    Eur J Epidemiol; 2019 Mar; 34(3):247-258. PubMed ID: 30353266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of coronary heart disease mortality with risk factors according to length of follow-up and serum cholesterol level in men: the Oslo Study cohort.
    Holme I; Tonstad S
    Eur J Prev Cardiol; 2013 Feb; 20(1):168-75. PubMed ID: 22131130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimated Glomerular Filtration Rate and Mortality among Patients with Coronary Heart Disease.
    Chen Q; Zhang Y; Ding D; Xia M; Li D; Yang Y; Li Q; Liu J; Chen X; Hu G; Ling W
    PLoS One; 2016; 11(8):e0161599. PubMed ID: 27537335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys.
    Pajak A; Jankowski P; Kawecka-Jaszcz K; Surowiec S; Wolfshaut R; Loster M; Batko K; Badacz L; Dubiel JS; Grodecki J; Grodzicki T; Maciejewicz J; Mirek-Bryniarska E; Piotrowski W; Smielak-Korombel W; Tracz W
    Kardiol Pol; 2009 Dec; 67(12):1353-9. PubMed ID: 20054766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health related quality of life in coronary patients and its association with their cardiovascular risk profile: results from the EUROASPIRE III survey.
    De Smedt D; Clays E; Annemans L; Doyle F; Kotseva K; Pająk A; Prugger C; Jennings C; Wood D; De Bacquer D
    Int J Cardiol; 2013 Sep; 168(2):898-903. PubMed ID: 23201081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-specific impact of diabetes mellitus on the risk of cardiovascular mortality: An overview from the evidence for Cardiovascular Prevention from Observational Cohorts in the Japan Research Group (EPOCH-JAPAN).
    Hirakawa Y; Ninomiya T; Kiyohara Y; Murakami Y; Saitoh S; Nakagawa H; Okayama A; Tamakoshi A; Sakata K; Miura K; Ueshima H; Okamura T;
    J Epidemiol; 2017 Mar; 27(3):123-129. PubMed ID: 28142033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.